LeadIQ logo
Learn more at LeadIQ.com

Insights

New Product Launches Akebia Therapeutics recently launched Vafseo, a drug for anemia related to chronic kidney disease, in Germany, Austria, and the Netherlands. This presents an opportunity for sales expansion into more regions and markets.

Investment Interest Compass Ion Advisors LLC has made a new investment in Akebia Therapeutics. This financial backing indicates investor confidence and potential growth, opening doors for strategic collaborations and partnerships.

Leadership Change Erik Ostrowski was appointed as the Senior Vice President, Chief Financial Officer, and Chief Business Officer at Akebia Therapeutics. His new role may lead to revised business strategies and connections beneficial for sales outreach.

Strategic Financing Akebia Therapeutics secured $55 million in term loan financing, showcasing financial stability and readiness for further expansion. This capital injection can provide resources for increased marketing and sales efforts.

Product Approval & Availability Vafseo tablets, approved by the FDA for treating anemia in CKD patients receiving dialysis, are set to launch in January 2025. Anticipating this launch, sales teams could prepare marketing campaigns to promote the product's availability.

Similar companies to Akebia Therapeutics

Akebia Therapeutics Tech Stack

Akebia Therapeutics uses 8 technology products and services including WordPress, UltiPro, Modernizr, and more. Explore Akebia Therapeutics's tech stack below.

  • WordPress
    Content Management System
  • UltiPro
    Human Resource Management System
  • Modernizr
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Google
    Miscellaneous
  • RSS
    Miscellaneous
  • Module Federation
    Miscellaneous
  • Priority Hints
    Performance

Media & News

Akebia Therapeutics's Email Address Formats

Akebia Therapeutics uses at least 1 format(s):
Akebia Therapeutics Email FormatsExamplePercentage
FLast@akebia.comJDoe@akebia.com
92%
LFirst@akebia.comDJohn@akebia.com
5%
Last@akebia.comDoe@akebia.com
2%
FMLast@akebia.comJMDoe@akebia.com
1%

Frequently Asked Questions

Where is Akebia Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Akebia Therapeutics's main headquarters is located at 245 First Street Suite 1400 Cambridge, MA 02142 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Akebia Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Akebia Therapeutics's main corporate office by phone at +1-617-871-2098. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Akebia Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Akebia Therapeutics is a publicly traded company; the company's stock symbol is AKBA.

What is Akebia Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Akebia Therapeutics's official website is akebia.com and has social profiles on LinkedIn.

How much revenue does Akebia Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, Akebia Therapeutics's annual revenue reached $75M.

What is Akebia Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Akebia Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Akebia Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, Akebia Therapeutics has approximately 246 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Accounting Officer: R. M.Vice President Of Sales: G. R.Vice President Clinical Pharmacology, Modeling And Simulation: K. D.. Explore Akebia Therapeutics's employee directory with LeadIQ.

What industry does Akebia Therapeutics belong to?

Minus sign iconPlus sign icon
Akebia Therapeutics operates in the Biotechnology Research industry.

What technology does Akebia Therapeutics use?

Minus sign iconPlus sign icon
Akebia Therapeutics's tech stack includes WordPressUltiProModernizrjQuery MigrateGoogleRSSModule FederationPriority Hints.

What is Akebia Therapeutics's email format?

Minus sign iconPlus sign icon
Akebia Therapeutics's email format typically follows the pattern of . Find more Akebia Therapeutics email formats with LeadIQ.

How much funding has Akebia Therapeutics raised to date?

Minus sign iconPlus sign icon
As of September 2024, Akebia Therapeutics has raised $37M in funding. The last funding round occurred on Jan 30, 2024 for $37M.

When was Akebia Therapeutics founded?

Minus sign iconPlus sign icon
Akebia Therapeutics was founded in 2007.
Akebia Therapeutics

Akebia Therapeutics

Biotechnology ResearchMassachusetts, United States201-500 Employees

Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease. 

Please review our social media guidelines at: https://akebia.com/social-media-guidelines/

Section iconCompany Overview

Headquarters
245 First Street Suite 1400 Cambridge, MA 02142 US
Phone number
+1-617-871-2098
Website
akebia.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AKBA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
201-500

Section iconFunding & Financials

  • $37M

    Akebia Therapeutics has raised a total of $37M of funding over 8 rounds. Their latest funding round was raised on Jan 30, 2024 in the amount of $37M.

  • $50M$100M

    Akebia Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $37M

    Akebia Therapeutics has raised a total of $37M of funding over 8 rounds. Their latest funding round was raised on Jan 30, 2024 in the amount of $37M.

  • $50M$100M

    Akebia Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.